Skip to main content

Clinical Trials

Search among the clinical trials we have open at the Vall d'Hebron Research Institute.

Phase Title Sort descending Service Recruitment
Phase II A 52-week randomized,double-blind, placebocontrolled, multi-center… Endocrinology No
Phase III A controlled, open-label post-authorisation efficacy and safety… Nephrology Yes
Phase III A Multicenter, Adaptive, Randomized, Controlled Trial Platform To… Infectious No
Phase III A multi-center, open-label, uncontrolled, single-arm, extension study… Internal Medicine Yes
Phase III A multi-center, randomized, double-blind, placebo controlled,… Cardiology Yes
Phase II A Multicenter, Randomized, Double-Blind, Placebo-Controlled,… Neurology Yes
Phase II A Multicentre Controlled Open Randomized Clinical Trial to evaluate… Infectious Yes
Phase II A MULTI-PART, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 2… Internal Medicine No
Phase II A parallel-group treatment, proof-of-concept Phase 2, multicenter,… Anesthesia No
Phase II A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter… Rheumatology No
Phase II A phase 2, multicenter, open-label study to assess appropriate dosing… Pediatric Oncohematology Yes
Phase II A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled… Nephrology Yes
Phase II A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the… Nephrology No
Phase II A Phase 2 Open-Label Study of Continuation Treatment With Combination… General Pediatrics and Specialties Yes
Phase II “A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to… Neurology Yes
Phase III “A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo controlled… Psychiatry No
Phase II A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the… Pneumology Yes
Phase III A Phase 3, Multicenter, 12-Week, Double-Blind,Placebo Controlled Study to… Neurology Yes
Phase III A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study… Internal Medicine Yes
Phase III A phase 3 multicenter, randomized, placebo-controlled, double-blind… Endocrinology Yes
Phase III A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy… Pneumology Yes
Phase III A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445… Obstetrics Yes
Phase III A phase 3, open-label study of adjunctive ganaxolone (GNX) treatment in… Neurology No
Phase III A Phase 3, randomised, double-blind, parallel-group, event driven,… Endocrinology No